Jones E - Search Results

1

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.

Hindley JP, Ferreira C, Jones E, Lauder SN, Ladell K, Wynn KK, Betts GJ, Singh Y, Price DA, Godkin AJ, Dyson J, Gallimore A. Hindley JP, et al. Among authors: jones e. Cancer Res. 2011 Feb 1;71(3):736-46. doi: 10.1158/0008-5472.CAN-10-1797. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156649 Free PMC article.

2

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.

Smith DC, Gallimore A, Jones E, Roberts B, Lord JM, Deeks E, Cerundolo V, Roberts LM. Smith DC, et al. Among authors: jones e. J Immunol. 2002 Jul 1;169(1):99-107. doi: 10.4049/jimmunol.169.1.99. J Immunol. 2002. PMID: 12077234

3

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies.

Simon AK, Gallimore A, Jones E, Sawitzki B, Cerundolo V, Screaton GR. Simon AK, et al. Among authors: jones e. Cancer Cell. 2002 Oct;2(4):315-22. doi: 10.1016/s1535-6108(02)00151-4. Cancer Cell. 2002. PMID: 12398895 Free article.

4

CD25+ regulatory T cells and tumor immunity.

Jones E, Dahm-Vicker M, Golgher D, Gallimore A. Jones E, et al. Immunol Lett. 2003 Jan 22;85(2):141-3. doi: 10.1016/s0165-2478(02)00240-7. Immunol Lett. 2003. PMID: 12527220 Review.

5

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.

Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Golgher D, et al. Among authors: jones e. Eur J Immunol. 2002 Nov;32(11):3267-75. doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 12555672 Free article.

6

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Jones E, Price DA, Dahm-Vicker M, Cerundolo V, Klenerman P, Gallimore A. Jones E, et al. Immunology. 2003 May;109(1):68-75. doi: 10.1046/j.1365-2567.2003.01636.x. Immunology. 2003. PMID: 12709019 Free PMC article.

7

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V, Gallimore A. Jones E, et al. Cancer Immun. 2002 Feb 22;2:1. Cancer Immun. 2002. PMID: 12747746

8

Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.

Wooldridge L, Hutchinson SL, Choi EM, Lissina A, Jones E, Mirza F, Dunbar PR, Price DA, Cerundolo V, Sewell AK. Wooldridge L, et al. Among authors: jones e. J Immunol. 2003 Dec 15;171(12):6650-60. doi: 10.4049/jimmunol.171.12.6650. J Immunol. 2003. PMID: 14662868

9

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice.

Jones E, Golgher D, Simon AK, Dahm-Vicker M, Screaton G, Elliott T, Gallimore A. Jones E, et al. Novartis Found Symp. 2004;256:149-52; discussion 152-7, 259-69. Novartis Found Symp. 2004. PMID: 15027488 Review.

10

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.

Bushell A, Jones E, Gallimore A, Wood K. Bushell A, et al. Among authors: jones e. J Immunol. 2005 Mar 15;174(6):3290-7. doi: 10.4049/jimmunol.174.6.3290. J Immunol. 2005. PMID: 15749860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,411 results

Search Page

Filters